Cargando…
Antimicrobial peptide LL-37 and recombinant human mannose-binding lectin express distinct age- and pathogen-specific antimicrobial activity in human newborn cord blood in vitro
Background: There is a need to prevent and treat infection in newborns. One approach is administration of antimicrobial proteins and peptides (APPs) such as LL-37, a membrane-active cathelicidin antimicrobial peptide, and mannose-binding lectin (MBL), a pattern-recognition protein that binds to micr...
Autores principales: | Scheid, Annette, Li, Ning, Jeffers, Carleen, Borriello, Francesco, Joshi, Sweta, Ozonoff, Al, Pettengill, Matthew, Levy, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143923/ https://www.ncbi.nlm.nih.gov/pubmed/30271580 http://dx.doi.org/10.12688/f1000research.14736.1 |
Ejemplares similares
-
LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023) -
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020) -
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021) -
Transformation of Human Cathelicidin LL-37 into Selective,
Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014) -
The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)